Merck

Darmstadt, Germany Founded: 1668 • Age: 358 yrs
Merck is engaged in science and technology solutions globally.
Annual revenue $22.0B Latest available
Total funding - 34 rounds
Employees 376 Tracked headcount
Investors 4 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Merck

Merck is a company based in Darmstadt (Germany) founded in 1668. It operates as a Professional Services and Direct-to-Consumer (D2C). The company has 376 employees as of December 31, 2024. Merck has completed 18 acquisitions, including AmpTec, Ares Serono and Azem. Merck offers products and services including Life Science Solutions, Healthcare Solutions, and Electronics Materials. Merck operates in a competitive market with competitors including Roivant Sciences, AbbVie, Gilead, Lilly and Vertex Pharmaceuticals, among others.

  • Headquarter Darmstadt, Germany
  • Employees 376 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Merck Kgaa
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $21.98 B (USD)
    0.78
    as on Dec 31, 2024
  • Net Profit
    $2.89 B (USD)
    -1.66
    as on Dec 31, 2024
  • EBITDA
    $6.41 B (USD)
    5.89
    as on Dec 31, 2024
  • Latest Funding Round
    $271.17 K (USD), Grant

    Aug 11, 2023

  • Investors
  • Employee Count
    376

    as on Dec 31, 2024

  • Investments & Acquisitions
    AmpTec

    & 17 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Merck

Merck is a publicly listed company on the IDX with ticker symbol MERK in Indonesia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: IDX · Ticker: MERK · Sector: Health technology · Indonesia

Products & Services of Merck

Merck offers a comprehensive portfolio of products and services, including Life Science Solutions, Healthcare Solutions, and Electronics Materials.

Product name locked
Category locked
Primary

Tools and services for scientific research are provided.

Product name locked
Category locked
Locked

Innovative treatments for various medical conditions are developed.

Product name locked
Category locked
Locked

Advanced materials for tech industries are manufactured here.

People of Merck

Headcount 10000+
Employee Profiles 546
Employee Profiles
People
Chris Minnich
Director, Coe Devices
People
Josie Downey
General Manager And Managing Director, Merck Healthcare, Australia And New Zealand
People
Eric Andrieu
Directeur Des Ressources Humaines France
People
Niveditha S
Analyst

Unlock access to complete

Funding Insights of Merck

Investors in Merck

Merck has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include European Union, BMBF and Ministry of Economy, Finance and Industrial and Digital Sovereignty.

All
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Education and research policies are overseen by the ministry.
Locked Locked Locked
Premium access

Investor details for Merck

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Merck

Merck has strategically engaged in corporate development activities, having acquired 18 companies. Notable acquisitions include AmpTec, Ares Serono and Azem.

Investments
Premium access

Investment portfolio details for Merck

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Small molecule therapeutics are developed for cancer and rare diseases.
Locked Locked 2017 Locked
Microbioreactors for research purposes are manufactured by Erbi Bio.
Locked Locked 2016 Locked
Small-batch liposomal and pegylated formulations are developed and manufactured.
Locked Locked 2016 Locked
Premium access

Complete acquisition details for Merck

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Merck

Premium access

Detailed financials for Merck

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Merck Comparisons

Merck Primary company
Description
Merck is engaged in science and technology solutions globall...
Location
Darmstadt, Germany
Founded Year
1668
Annual Revenue
$21.98 B (USD)
Net Profit
$2.89 B (USD)
EBITDA
$6.41 B (USD)
Employees
376
As of 2024
Premium access

Peer comparison for Merck

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Merck

Merck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roivant Sciences, AbbVie, Gilead, Lilly and Vertex Pharmaceuticals, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
Locked Locked Locked
Biopharmaceutical research and drug development are conducted globally by AbbVie.
Locked Locked Locked
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
Locked Locked Locked
Traditional pharmaceutical medicines are developed for multiple health fields.
Locked Locked Locked
Developer of drugs for the treatment of multiple disorders
Premium access

Detailed competitors of Merck

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Merck

Premium access

Complete news archive for Merck

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Merck

Merck was founded in 1668 and raised its 1st funding round 346 years after it was founded.

Merck is headquartered in Darmstadt, Germany. It is registered at Darmstadt, Hesse, Germany.

As of Dec 31, 2024, the latest employee count at Merck is 376.

Annual revenue of Merck is $21.98B as on Dec 31, 2024.

Merck is recognized as a leader in science and technology, focusing on Electronics, Healthcare, and Life Science sectors. Solutions are developed to address major illnesses, advance technological innovations, and support scientific research. Operations are conducted across 65 countries, with efforts centered on sustainability and digitalization. Partnerships and internal innovations are prioritized to elevate humanity and create a healthier future.

Merck's top competitors include Roivant Sciences, AbbVie and Lilly.

Merck offers Life Science Solutions, Healthcare Solutions, and Electronics Materials.

Yes, Merck is publicly traded on IDX under the ticker symbol MERK.

Merck has made 18 acquisitions, including AmpTec, Ares Serono, and Azem.

Merck has 4 investors. Key investors include European Union, BMBF, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and Military Health.

The ticker symbol of Merck is MERK on IDX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available